These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 809105)

  • 1. Thyrotropin releasing factor (TRF) regulation of rotation in the non-lesioned rat.
    Cohn ML; Cohn M; Taylor FH
    Brain Res; 1975 Oct; 96(1):134-7. PubMed ID: 809105
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Barrel rotation' induced by somatostatin in the non-lesioned rat.
    Cohn ML; Cohn M
    Brain Res; 1975 Oct; 96(1):138-41. PubMed ID: 809106
    [No Abstract]   [Full Text] [Related]  

  • 3. Central effects of thyrotropin-releasing factor (TRF); interaction with some antipsychotic drugs.
    Mora S; Loizzo A; Longo VG
    Pharmacol Biochem Behav; 1976 Mar; 4(3):279-82. PubMed ID: 819939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic involvement in the locomotor stimulant or satiety action of thyrotropin-releasing hormone and amphetamine.
    Shian LR; Wu MH; Lin MT; Ho LT
    Pharmacology; 1985; 30(5):259-65. PubMed ID: 3923502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive augmentation of locomotor activity in mice by long-term treatment with thyrotropin releasing hormone.
    Ushijima I; Yamada K; Noda Y; Furukawa T
    Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):29-37. PubMed ID: 6437352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral changes in 6-hydroxydopamine-treated rotation rats after delivery of various neuromodifying agents by means of a stereotactically implanted pellet to the brain.
    Yoshida M; Torigoe R; Ohtsuru K; Kuramoto S
    Stereotact Funct Neurosurg; 1990; 54-55():342-6. PubMed ID: 2127860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amphetamine and apomorphine on ACTH and growth hormone secretion.
    Kokka N; Masuoka DT
    Proc West Pharmacol Soc; 1976; 19():209-11. PubMed ID: 186808
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of behavioral events by thyrotropin releasing factor and cyclic AMP.
    Cohn ML; Cohn M; Krzysik BA; Taylor FH
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):129-33. PubMed ID: 189323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of ethanol narcosis by thyrotropin releasing hormone.
    Breese GR; Cott JM; Cooper BR; Prange AJ; Lipton MA
    Life Sci; 1974 Mar; 14(6):1053-63. PubMed ID: 4207201
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of TRH on the central nervous system.
    Aslanov AS; Lavretskaya GI
    Neurosci Behav Physiol; 1988; 18(2):130-4. PubMed ID: 3137486
    [No Abstract]   [Full Text] [Related]  

  • 13. Methodone interaction with apomorphine- and amphetamine-induced turning.
    Stratten WP
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the calcium channel blockers on rotation induced by apomorphine and amphetamine in rats lesioned with 6-hydroxydopamine].
    Tabernero C; Pardo B; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(2):49-53. PubMed ID: 1907126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thyrotropin-releasing hormone on locomotor activity, operant performance and ingestive behavior.
    Vogel RA; Cooper BR; Barlow TS; Prange AJ; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1979 Feb; 208(2):161-8. PubMed ID: 105126
    [No Abstract]   [Full Text] [Related]  

  • 16. Locomotor hyperactivity induced by MK-801 in rats.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of thyroliberin on the central nervous system].
    Aslanov AS; Lavretskaia GI
    Probl Endokrinol (Mosk); 1987; 33(4):51-5. PubMed ID: 3116536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
    van der Elst MC; Wunderink YS; Ellenbroek BA; Cools AR
    Psychopharmacology (Berl); 2007 Jan; 190(1):93-102. PubMed ID: 17031706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of the antidepressive and learning-stimulating effects of thyroliberin and its analogs].
    Zakusov VV; Ostrovskaia RU; Kosoĭ MIu; Gudasheva TA; Skoldinov AP
    Biull Eksp Biol Med; 1986 Jul; 102(7):39-41. PubMed ID: 3089346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone release in the rat: effects of somatostatin and thyrotropin-releasing factor.
    Brown M; Vale W
    Endocrinology; 1975 Nov; 97(5):1151-6. PubMed ID: 810343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.